These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

726 related articles for article (PubMed ID: 31881337)

  • 1. The balance between breast cancer and the immune system: Challenges for prognosis and clinical benefit from immunotherapies.
    Baxevanis CN; Fortis SP; Perez SA
    Semin Cancer Biol; 2021 Jul; 72():76-89. PubMed ID: 31881337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer.
    Sofopoulos M; Fortis SP; Vaxevanis CK; Sotiriadou NN; Arnogiannaki N; Ardavanis A; Vlachodimitropoulos D; Perez SA; Baxevanis CN
    Cancer Immunol Immunother; 2019 Nov; 68(11):1733-1745. PubMed ID: 31598757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour-infiltrating lymphocytes and the emerging role of immunotherapy in breast cancer.
    Luen SJ; Savas P; Fox SB; Salgado R; Loi S
    Pathology; 2017 Feb; 49(2):141-155. PubMed ID: 28049579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-Infiltrating Lymphocytes in Colorectal Cancer: The Fundamental Indication and Application on Immunotherapy.
    Bai Z; Zhou Y; Ye Z; Xiong J; Lan H; Wang F
    Front Immunol; 2021; 12():808964. PubMed ID: 35095898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell-based breast cancer immunotherapy.
    Pilipow K; Darwich A; Losurdo A
    Semin Cancer Biol; 2021 Jul; 72():90-101. PubMed ID: 32492452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving Breast Cancer Responses to Immunotherapy-a Search for the Achilles Heel of the Tumor Microenvironment.
    Jenkins S; Wesolowski R; Gatti-Mays ME
    Curr Oncol Rep; 2021 Mar; 23(5):55. PubMed ID: 33755828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of immune infiltrates as prognostic biomarkers in patients with breast cancer.
    Baxevanis CN; Sofopoulos M; Fortis SP; Perez SA
    Cancer Immunol Immunother; 2019 Oct; 68(10):1671-1680. PubMed ID: 30905043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Innate Immunity in Breast Cancer Therapy: A Narrative Review.
    Ye Y; Xu C; Chen F; Liu Q; Cheng N
    Front Immunol; 2021; 12():771201. PubMed ID: 34899721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing the Tumor Microenvironment and Its Prognostic Impact in Breast Cancer.
    Zhang W; Lee A; Tiwari AK; Yang MQ
    Cells; 2024 Sep; 13(18):. PubMed ID: 39329702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of tumor microenvironment in primary and paired metastatic ER+/HER2- breast cancers: results of a pilot study.
    Zeppellini A; Galimberti S; Leone BE; Pacifico C; Riva F; Cicchiello F; Capici S; Maggioni C; Sala L; Cazzaniga ME
    BMC Cancer; 2021 Mar; 21(1):260. PubMed ID: 33691674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors.
    Balta E; Wabnitz GH; Samstag Y
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guardians and Mediators of Metastasis: Exploring T Lymphocytes, Myeloid-Derived Suppressor Cells, and Tumor-Associated Macrophages in the Breast Cancer Microenvironment.
    Ruocco MR; Gisonna A; Acampora V; D'Agostino A; Carrese B; Santoro J; Venuta A; Nasso R; Rocco N; Russo D; Cavaliere A; Altobelli GG; Masone S; Avagliano A; Arcucci A; Fiume G
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Tertiary Lymphoid Structures for Tumor Immunotherapy.
    Tang H; Qiu X; Timmerman C; Fu YX
    Methods Mol Biol; 2018; 1845():275-286. PubMed ID: 30141019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Multifaceted Nature of Tumor Microenvironment in Breast Carcinomas.
    Annaratone L; Cascardi E; Vissio E; Sarotto I; Chmielik E; Sapino A; Berrino E; Marchiò C
    Pathobiology; 2020; 87(2):125-142. PubMed ID: 32325459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor microenvironment of human breast cancer, and feline mammary carcinoma as a potential study model.
    Nascimento C; Ferreira F
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188587. PubMed ID: 34237352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune parameters associated with survival in metaplastic breast cancer.
    Chao X; Liu L; Sun P; Yang X; Li M; Luo R; Huang Y; He J; Yun J
    Breast Cancer Res; 2020 Aug; 22(1):92. PubMed ID: 32811533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
    Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
    Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility.
    Ravelli A; Roviello G; Cretella D; Cavazzoni A; Biondi A; Cappelletti MR; Zanotti L; Ferrero G; Ungari M; Zanconati F; Bottini A; Alfieri R; Petronini PG; Generali D
    Tumour Biol; 2017 Apr; 39(4):1010428317695023. PubMed ID: 28378631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-infiltrating lymphocytes in the immunotherapy era.
    Paijens ST; Vledder A; de Bruyn M; Nijman HW
    Cell Mol Immunol; 2021 Apr; 18(4):842-859. PubMed ID: 33139907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.